Showing 91 - 100 of 224 results
. Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development Director, Center for Natural Products, Drug Discovery and Development
in Forensic Toxicology and a minor in Statistics. Dr. Grundmann’s research interests include the search for new treatment options from natural products for CNS diseases
recognizes outstanding student research in the area of natural products and supports Al-Awadhi’s travel to the American Society of Pharmacognosy Annual Meeting in Portland, Oregon, July
professional interests are in the field of pharmacognosy, which is the study of natural products. She received a UF Distinguished Alumnus Award in 2015.
large-scale or focused synthetic libraries as well as natural products for small molecule modulators of target or pathway activity. Furthermore, dietary components including marine
Salvador, Medicinal Chemistry: “Novel Bioactive Natural Products from the Marine Cyanobacterium Symploca sp. as Leads for Drug Discovery” Levitt Division Efe Eworuke, Pharmaceutical
6268Intermediate Pharmacoepidemiology3Spring MCPHA 6356Structure Determination of Complex Natural Products3Spring PCPHA 6416Pharmaceutical Analysis3Spring PCPHA 6418Model
of medicinal chemistry and the Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development.
Dr. Müller is the Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Germany where he also leads the Department of Microbial Natural Products. His lecture is titled, "Basic microbiology, chemistry and synthetic biotechnology to identify and characterize antibiotics from microbes."
Dr. Loesgen is the Terence Brandshaw chemistry professor at Oregon State University. Her lecture is titled "Drug discovery with microbial natural products – from new gene activation techniques to anticancer leads."
